topiramate / Generic mfg.  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
topiramate / Generic mfg.
2005-001339-31: Estudio abierto, aleatorizado, multicéntrico con extensión abierta para evaluar la farmacocinética y seguridad de la solución oral líquida y de la formulación dispersable de topiramato como terapia adyuvante al tratamiento antiepiléptico concomitante en niños (de 1 a 23 meses de edad, ambos inclusive) que sufren crisis Parciales Refractarias

Ongoing
1
10
Europe
Topiramato solución oral, Topiramato cápsulas dispersables, F017, Topamax, Topamax
Jansenn Cilag International N.V.
Epilepsias parciales y otras crisis
 
 
2008-004402-13: Etude en neuropsychologie, imagerie fonctionnelle et pharmacologie des effets cognitifs chez l\'enfant épileptique traité par le topiramate ou le clobazam

Ongoing
1
80
Europe
Inserm
Epilepsie partielle crypotgénique/ symptomatique
 
 
NCT03120468: Topiramate Augmenting Strategies for the Treatment of Alcohol Use Disorder

Active, not recruiting
1
16
US
Topiramate and N-Acetyl Cysteine, Topamax, Topiramate and Placebo, Topamax; Sugar Pill
Nassima Ait-Daoud Tiouririne
Alcoholism
01/21
01/21
NCT04613024: Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

Withdrawn
1
70
RoW
Topamax, Gabapentin
Stanford University
Weight Loss, Pain, Postoperative
08/24
07/25
PHARMATOP, NCT04986631: Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth:

Active, not recruiting
1
65
US
Topiramate Tablets
University of Minnesota
Obesity, Childhood
11/24
11/25

Download Options